In recent academic literature, there have been more and more publications documenting that biochemical pathways in canine cancer cells are often dysregulated, and therefore, targeted therapies are likely of value.
Over 20 peer reviewed publications showcase these points.
Here are a few:
Transitional Cell Carcinoma (TCC)
Apocrine Gland Anal Sac Adenocarcinoma (AGASACA)